[婴儿肉毒症:一个被低估的问题. 一个审查]
V A Malov1, V V Maleev2, V P Chulanov1
1Sechenov First Moscow State Medical University (Sechenov University).
Terapevticheskii arkhiv
|December 28, 2024
概括
婴儿肉毒是一种罕见的疾病,发生在婴儿摄入肠道中生长的子时,产生毒素并引起. 这篇文章详细介绍了它的独特特征,诊断和治疗.
科学领域:
- 医学微生物学 医学微生物学
- 儿童传染病 儿童传染病
- 神经科学是一个神经科学.
背景情况:
- 婴儿肉毒症是一种罕见的神经麻性疾病,由 *Clostridium botulinum* 子引起.
- 与食源性肉毒症不同,婴儿肉毒症涉及肠道子发芽和毒素*in situ*的产生.
- 这种形式的肉毒主义仅在婴儿中被诊断出来,具有独特的临床和流行病学特征.
研究的目的:
- 提供关于婴儿肉毒的全面概述,这是该国鲜为人知的疾病.
- 阐明婴儿肉毒的独特病变发生,临床表现和流行病学因素.
- 详细说明婴儿肉毒主义的诊断方法,实验室确认和当前治疗策略.
主要方法:
- 关于婴儿肉毒的现有文献和案例研究的审查.
- 对流行病学数据和与婴儿肉毒主义相关的风险因素的分析.
- 对婴儿肉毒主义的当前诊断和治疗方法的综合.
主要成果:
- 婴儿肉毒的发病包括子的摄入,肠道殖民化和*in situ*毒素的产生,导致性.
- 特定的临床特征和流行病学风险因素使婴儿肉毒主义与其他形式区别开来.
- 确定的诊断标准和实验室方法有助于确定婴儿肉毒的病因.
结论:
- 婴儿肉毒症由于其独特的病理生理学和临床表现,需要专门的理解.
- 早期诊断和适当的治疗对于改善受影响婴儿的结果至关重要.
- 需要进一步的研究和提高认识,以解决婴儿这种危及生命的疾病.
相关概念视频
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:12Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...